EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Association between statin use and risk of gallstone disease and cholecystectomy: a meta-analysis of 590,086 patients

Yu Chang, Hong-Min Lin, Kuan-Yu Chi, Wan-Ying Lin, Tsung-Ching Chou

PeerJ · 2023

DOI: 10.7717/peerj.15149 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PeerJ, 2023. Verfasst von Yu Chang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cholelithiasis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Statins have been reported to reduce the risk of gallstone disease. However, the impacts of different durations of statin use on gallstone disease have not been clarified. The aim of this study is toperform a systematic review with meta-analysis to update and to elucidate the association between statin use and the risk of gallstone disease and cholecystectomy.

Methods

Medline, Embase and Cochrane Library were searched from the inception until August 2022 for relevant articles investigating the difference in the risk of gallstone disease between statin users and non-users (PROSPERO, ID: CRD42020182445). Meta-analyses were conducted using odds ratios (ORs) with corresponding 95% confidence intervals (CIs) to compare the risk of gallstone disease and cholecystectomy between statin user and nonusers.

Results

Eight studies enrolling 590,086 patients were included. Overall, the use of statins was associated with a marginally significant lower risk of gallstone disease than nonusers (OR, 0.91; 95% CI [0.82–1.00]). Further subgroup analysis showed that short-term users, medium-term users, and long-term users were associated with a significantly higher risk (OR, 1.18; 95% CI [1.11–1.25]), comparable risk (OR, 0.93; 95% CI [0.83–1.04]), and significantly lower risk of gallstone diseases (OR, 0.78; 95% CI [0.68–0.90]) respectively, compared to nonusers.

Conclusions

Patients with medium-term or long-term use of statins without discontinuation are at a lower risk of gallstone disease or cholecystectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsCholelithiasisHumansCholecystectomyRiskOdds Ratio

Stichwörter der Autor:innen

GallstoneStatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Family Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
  • Department of Education, Center for Evidence-Based Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
  • Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan.

Zitieren

APA

Chang, Y., Lin, H. M., Chi, K. Y., Lin, W. Y., & Chou, T. C. (2023). Association between statin use and risk of gallstone disease and cholecystectomy: a meta-analysis of 590,086 patients. PeerJ. https://doi.org/10.7717/peerj.15149

Vancouver

Chang Y, Lin HM, Chi KY, Lin WY, Chou TC. Association between statin use and risk of gallstone disease and cholecystectomy: a meta-analysis of 590,086 patients. PeerJ. 2023. doi:10.7717/peerj.15149

BibTeX
@article{Chang2023,
  author = {Chang, Yu and Lin, Hong-Min and Chi, Kuan-Yu and Lin, Wan-Ying and Chou, Tsung-Ching},
  title = {Association between statin use and risk of gallstone disease and cholecystectomy: a meta-analysis of 590,086 patients},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.15149}
}
Kostenlos starten →